Androxal: Clinical Trials

14 trials of Androxal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 1 withdrawn. 8 Phase 3, 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 38Completed 7, Withdrawn 1
Phase 24Completed 3, Withdrawn 1
Phase 13Completed 3

Follow Androxal: new trials by email Literature Review of Androxal trials Research Report on Androxal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Androxal - Secondary Hypogonadism
Phase 1CompletedRepros Therapeutics Inc.62014-12-012015-03-12
Androxal in Male Infertility
Enclomiphene citrate, Placebo - Infertility
Phase 2 / Phase 3WithdrawnBaylor College of Medicine2014-09-222019-07-11
Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males
Androxal, Placebo - Drug-drug Interaction
Phase 1CompletedRepros Therapeutics Inc.302014-05-012014-08-11
A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
Androxal, Placebo - Pharmacokinetics, Tolerability
Phase 1CompletedRepros Therapeutics Inc.92013-10-012014-08-11
Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
enclomiphene citrate, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1812012-11-012015-05-27
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.3002012-11-012014-04-16
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
enclomiphene citrate, Placebo - Effect of Treatment on Bone Mineral Density
Phase 3CompletedRepros Therapeutics Inc.3002012-09-012014-10-01
Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
Androxal, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1512012-08-012015-05-27
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.4992012-05-012014-07-24
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
Androxal (enclomiphene citrate), Testosterone - Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.602011-06-012015-09-23
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Placebo, topical testosterone, Androxal - Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.832011-01-012014-07-28
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
Placebo, Androxal - Type 2 Diabetes Mellitus, Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.1022010-10-012014-07-24
Study to Evaluate the Safety and Efficacy of Androxalâ„¢ Treatment in Men With Secondary Hypogonadism
Androxal, AndroGel, Placebo - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1942006-03-012010-02-11
Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
Androxal - Secondary Hypogonadism
Phase 3CompletedRepros Therapeutics Inc.1042006-03-012014-06-27

Conditions studied

Hypogonadism (11)  ·  Diabetes Mellitus, Type 2 (1)  ·  Infertility (1)

Sponsors

Repros Therapeutics Inc. (13)  ·  Baylor College of Medicine (1)

Countries

United States (13)

Top investigators

Joseph S Podolski (4)  ·  Andre van As, MD, PhD (2)  ·  Barbara Cook, MD (1)  ·  Glenn Cunningham, MD (1)  ·  Jolene Berg, MD (1)  ·  Larry I. Lipshultz, MD (1)  ·  Larry Lipshultz, MD (1)

Results publications

PMID 25044085